NCT07285161

Brief Summary

The primary outcome is quality of life, with secondary outcomes including PTSD symptoms, and psychosocial functioning. We hypothesise that a low-dose intervention based on empowerment and self-directed goal setting will lead to (a) measurable improvements in veterans' quality of life and (b) reduced PTSD symptoms, and improved psychosocial functioning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 16, 2025

Completed
Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

3.8 years

First QC Date

December 3, 2025

Last Update Submit

December 3, 2025

Conditions

Keywords

VeteransPost Traumatic Stress DisorderPositive HealthRecoveryRandomised Controlled Trial

Outcome Measures

Primary Outcomes (1)

  • Change in Quality of Life Scores from Baseline, 6 Months, and 12 Months as Measured by the MANSA Questionnaire

    From enrollment to 12 months post-enrollment

Secondary Outcomes (2)

  • Change in PTSD Symptom Severity from Baseline, 6 Months, and 12 Months as Measured by the PCL-5 Questionnaire

    rom enrollment to 12 months post-enrollment

  • Change in Psychosocial Functioning from Baseline, 6 Months, and 12 Months as Measured by the TRACK 2.0 Questionnaire

    From enrollment to 12 months post-enrollment

Study Arms (2)

Intervention group

EXPERIMENTAL

Positive Health dialogue tool

Behavioral: Positive Health dialogue tool

Control group

NO INTERVENTION

Interventions

This intervention is distinguished by the integration of a structured dialogue tool in two additional sessions, designed to enhance therapeutic engagement and reflection. Unlike standard trauma-focused therapy alone, this approach offers a unique combination of conventional treatment with a targeted communication strategy tailored to veterans with PTSD.

Intervention group

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • A formal PTSD diagnosis
  • At the start of treatment
  • Aged 18 until 64
  • Reading, writing, and speaking Dutch

You may not qualify if:

  • Alcohol or drug dependency
  • Severe cognitive impairments (e.g., dementia)
  • Acute suicide risk, as assessed during the intake procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reinier van Arkel, Psychotraumacentrum Zuid-Nederland

's-Hertogenbosch, North Brabant, 5211LJ, Netherlands

Location

MeSH Terms

Conditions

Combat DisordersStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Forty-four veterans diagnosed with PTSD were randomly assigned to either a treatment group, which received two additional sessions using the dialogue tool alongside standard trauma-focused therapy, or a control group receiving treatment as usual.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Drs.

Study Record Dates

First Submitted

December 3, 2025

First Posted

December 16, 2025

Study Start

December 1, 2020

Primary Completion

September 1, 2024

Study Completion

September 1, 2025

Last Updated

December 16, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

The datasets generated during and/or analysed during the current study will be stored in a nonpublicly available repository en will be available upon request from the corresponding author.

Locations